Book Review - Adobe InDesign CS2 One-On-One by Deke McClelland

As with all the One-on-One series, Adobe InDesign CS2 One-On-One is based on the Read-Watch-Do approach of learning. In each of the 12 lessons contained in this book the method is to read the chapter, watch the video and do the exercises. Add to that, your personal trainer is Deke McClelland, an established expert with over 20 years of professional training experience.Adobe InDesign CS2 One-On-One is very systematic in its approach, clear in its communication and very user-friendly.

There are over two hours of DVD video and over 850 full color images, diagrams and screenshots that will illustrate your every step. Lesson one shows you how to start a document, set up margins, create custom workspaces and work with Adobe Bridge. Lesson two focuses on text flow by introducing the mechanics of frames and text blocks.

Imperial Lending Simplifies Compliance Process with Mavent’s MC 2 ...

IRVINE, Calif - Mavent Inc., a leading provider of automated compliance solutions to the financial services industry, announced that Castle Rock, Colo.-based Imperial Lending LLC is now utilizing the Mavent Compliance Console (MC2), a Web-based portal that enables lenders, loan purchasers and other mortgage-related businesses to submit loan data seamlessly for comprehensive regulatory and business compliance reviews. Imperial Lending is a wholesale lender that closes approximately $350 million in loans annually in 21 states.

The company's primary product offering, The Special Circumstance Loanâ„¢ addresses issues such as sub-500 credit scores, bankruptcy avoidance and borrowers with a record of late mortgage payments or are in foreclosure.Upon deciding to leave its previous compliance provider, the company selected the MC2 platform after several Wall Street firms "highly recommended Mavent," said Daryl Kruger, director of operations for Imperial Lending.

Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea ...

Senetek PLCwww.senetekplc.com, a life sciences product development company targeting the science of aging, has initiated clinical trials of its Pyratine 6 compound (PRK 124) for Acne Rosacea after evaluating positive results from a comparison of separate clinical trials of Pyratine 6 and Kinetin, Senetek's original anti-aging active ingredient. NAPA, CA, USA | Apr 11, 2007 | Senetek PLC (OTCBB:SNTKY), www.senetekplc.com, a life sciences product development company targeting the science of aging, has initiated clinical trials of its Pyratine 6 compound (PRK 124) for Acne Rosacea after evaluating positive results from a comparison of separate clinical trials of Pyratine 6 and Kinetin, Senetek's original anti-aging active ingredient.

An independent comparative analysis evaluated the effectiveness of Senetek's second-generation patented cytokinin, Pyratine 6 (PRK 124) relative to its original anti-aging active ingredient, Kinetin.